These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 9513810

  • 1. 2',3'-cyclic neucleotide 3'-phosphodiesterase activity in developing rat brain.
    Singh R, Shankar R.
    Indian J Physiol Pharmacol; 1998 Jan; 42(1):147-50. PubMed ID: 9513810
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Selective inhibitors of three forms of cyclic nucleotide phosphodiesterase--basic and potential clinical applications.
    Hidaka H, Endo T.
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984 Jan; 16():245-59. PubMed ID: 6144253
    [No Abstract] [Full Text] [Related]

  • 6. Rat brain and lung cyclic nucleotide phosphodiesterases: different responses to cromoglycate [proceedings].
    Saeed SA, Butt NM, Taylor WA.
    Biochem Soc Trans; 1979 Oct; 7(5):1037-8. PubMed ID: 229020
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cyclic nucleotides and cyclic nucleotide phosphodiesterases in kidneys from rats with experimental diabetes.
    Hoskins B, Luong HB.
    Res Commun Chem Pathol Pharmacol; 1981 Aug; 33(2):381-4. PubMed ID: 6272381
    [Abstract] [Full Text] [Related]

  • 9. Characteristics of the cyclic nucleotide phosphodiesterases in a transplantable pheochromocytoma and adrenal medulla of the rat.
    Levin RM, Weiss B.
    Cancer Res; 1978 Apr; 38(4):915-20. PubMed ID: 205349
    [No Abstract] [Full Text] [Related]

  • 10. [Phosphodiesterases of cyclic GMP].
    Wróblewska H, Gorczyca WA.
    Postepy Hig Med Dosw; 2001 Apr; 55(5):611-27. PubMed ID: 11795198
    [Abstract] [Full Text] [Related]

  • 11. Cyclic nucleotide phosphodiesterase of normal and leukemic lymphocytes. Kinetic properties and selective alteration of the activity of the multiple molecular forms.
    Hait WN, Weiss B.
    Mol Pharmacol; 1979 Nov; 16(3):851-64. PubMed ID: 231197
    [No Abstract] [Full Text] [Related]

  • 12. Drosophila cyclic nucleotide phosphodiesterases.
    Davis RL, Kauvar LM.
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984 Nov; 16():393-402. PubMed ID: 6326533
    [No Abstract] [Full Text] [Related]

  • 13. Membraneous and cytosolic cyclic-nucleotide phosphodiesterases in beef aorta: substrate specificity, endogenous inhibition and activation [proceedings].
    Ilien B, Morel A, Stierle A, Landry Y.
    Arch Int Physiol Biochim; 1978 Oct; 86(4):865-7. PubMed ID: 84582
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Properties of 3':5'-AMP- and 3':5'-GMP-phosphodiesterases in the retina].
    Usova AA.
    Ukr Biokhim Zh (1978); 1979 Oct; 51(1):35-40. PubMed ID: 218330
    [Abstract] [Full Text] [Related]

  • 18. Stimulation of rat liver cyclic 3':5'-nucleotide phosphodiesterase by cyclic GMP is dependent on enzyme concentration.
    Guan WR, Cheung WY.
    Arch Biochem Biophys; 1980 Oct 01; 204(1):191-8. PubMed ID: 6252844
    [No Abstract] [Full Text] [Related]

  • 19. The response of cyclic 3',5'-AMP and cyclic 3',5'-GMP phosphodiesterases to experimental diabetes.
    Perez de Gracia B, Rhoads AR, West WL.
    Experientia; 1980 Jul 15; 36(7):824-5. PubMed ID: 6249634
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.